Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betamethason + Calcipotriol (ausschl. in der Dafo Schaum), ATC D05AX22 für die Zeit 01.06.2026 - 31.05.2028
DAK-Gesundheit in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Betamethason + Calcipotriol (ausschl”. Bids close on 5 April 2028.
The work
Non-exclusive discount agreement for Betamethason + Calcipotriol (foam) for the period 01.06.2026 to 31.05.2028.
- Drug must be Betamethason + Calcipotriol (exclusively in the form of foam), ATC D05AX22
Key facts
- Contract period
- 01.06.2026 to 31.05.2028
- Evaluation
- Selection based on application letter
What it takes to qualify
Worth a closer look
- § 130a Absatz 8 SGB V
- Regularien des 4. Teils des GWB
- Deutsche Vergabeportal
- Offene Verfahren
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- AngebotsschreibenElectronic offer in text form per email
- Anerkennung der vertraglichen MaßgabenSigned contract with name or company stamp submitted by email
- Anlage 1 zum VertragFilled out and sent as email attachment
- Anlage 2 zum VertragExcel file with drug list sent as email attachment